OTC •
Healthcare •
Drug Manufacturers - General •
Quote as of 05/29/2026
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeOTC
Market Capitalization3,853.73 mln
Float322 mln
Earnings Date08/06/2026
EPS
0.72
Moderate
P / E
16.71
Moderately valued
Piotroski F-Score
9
/ 9
Exceptional
Beneish M-Score
-2.57
Likely reliable
Relative Strength
59
/ 100
Slightly ahead
Debt / Equity
0.00
Debt-free
Business Description
Santen Pharmaceutical is a Japanese company founded in 1890 and headquartered in Osaka, with operations spanning Asia, Europe, the Middle East, Africa, and beyond. The company focuses exclusively on eye care, developing and selling medicines and medical devices to treat conditions such as glaucoma, dry eye, allergic eye disease, and other vision-related disorders. Its portfolio includes both established treatments and a active pipeline of new drugs currently undergoing late-stage clinical trials.
